spacer
home > epc > autumn 2018 > quality compliance
PUBLICATIONS
European Pharmaceutical Contractor

Quality Compliance

Clinical and manufacturing departments tend to view quality and compliance from different perspectives because they are each focussed on different sets of compliance requirements (or perhaps the industry has become conditioned to seeing them as distinct on a perfunctory level). However, both groups can streamline compliance and increase effectiveness by applying many of the same quality practices to their compliance efforts. The core ideologies that form the basis of quality best practices are universal principles that apply not only to Good Manufacturing Practice (GMP) but to Good Clinical Practice (GCP) as well.

Intersections in Compliance Requirements

Clinical and manufacturing compliance efforts overlap in several comparable areas:

Deviations
Just as deviations in manufacturing are indicative of poor product quality, the lack of protocol adherence and inconsistencies in protocol implementation are signifiers of quality deficiencies in clinical trials. Since the study protocol is the single most important document in a clinical trial, adherence to the protocol is essential if quality is to be maintained. Correspondingly, strict observance of production standard operating procedures (SOPs) in manufacturing is critical to effective quality management. Parallel to an effective quality management system’s (QMS) criticality to deviation management in manufacturing, a systematised approach to clinical quality that emphasises clinical quality management principles can refine the focus on events that occur across studies and product lines and help manage actiontaking once a deviation issue has been identified. Always keep in mind that many deviation management principles can be applied in both manufacturing and clinical scenarios, such as identifying the source of an issue, identifying any areas that may be impacted, and using universal problemsolving techniques to conduct root cause analyses (ie, fishbone diagrams, the ‘5 Whys’ technique, etc).

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

 You must be a member of the site to make a comment.
spacer
Patricia Santos-Serrao, MasterControl’s Director of Clinical and Regulatory Solutions, started her life sciences career in 1994 with Schering-Plough and later joined Boehringer Ingelheim Pharmaceutical. Within both organisations, Patricia took a leading role in transitioning business processes, document management, and submission compilation from paper to electronic systems. She is a member of Regulatory Affairs Professional Society (RAPS) and earned her Regulatory Affairs Certification from RAPS and the Regulatory Affairs Certification Board. Patricia is a member of the Drug Information Association (DIA) and a member of the DIA-sponsored Trial Master File Reference Model working group.
spacer
Patricia Santos-Serrao
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Biopharma Group Celebrates Its 30th Anniversary

Established in 1989 as Biopharma Process Systems Ltd., the company initially focused on freeze drying equipment to the pharmaceutical & biotechnology industries and fast became a leading supplier of equipment in the UK & Ireland. In 1997, Biopharma Technology Ltd. was formed to offer a freeze drying R&D consultancy and lab services, with Dr. Kevin Ward joining the team in 2000 to expand the in-house expertise, services and training courses.
More info >>

White Papers

Data Technology as a Catalyst for Growth in the Life Sciences

AIGENPULSE

The life sciences industry is changing at a rapid pace. The need to develop the next blockbuster is pushing current technologies and methodologies to the limit. Scientific advancement over the last decades was embossed with giant leaps in knowledge, however, the new reality is that smaller incremental gains need to be carved out with ever increasing investments. In order to survive, progress and prosper in this new reality, a holistic approach to getting the most of research data is crucial. In fact, it will likely be the difference of being in existence in 5-10 years or not. For those bold enough to step into an area they are unfamiliar with, huge rewards are waiting.
More info >>

 
Industry Events

BioTrinity 2019

30 April - 1 May 2019, etc.venues 155 Bishopsgate, London EC2M 3YD

BioTrinity 2019 is taking place from the 30th April – 1stMay at etc.venues 155 Bishopsgatein London. Now in its 13th year, BioTrinity remains the leading Life Sciences Biopartnering and Investment conference in Europe, and generates unrivalled opportunities for life science companies, academics, investors, and major pharmaceutical players to come together to do deals and establish collaborations.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement